TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms. 2019

Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
Department of Neuroscience, UConn Health, Farmington, CT, United States.

Unresolved inflammation is a significant predictor for developing chronic pain, and targeting the mechanisms underlying inflammation offers opportunities for therapeutic intervention. During inflammation, matrix metalloproteinase (MMP) activity contributes to tissue remodeling and inflammatory signaling, and is regulated by tissue inhibitors of metalloproteinases (TIMPs). TIMP-1 and -2 have known roles in pain, but only in the context of MMP inhibition. However, TIMP-1 also has receptor-mediated cell signaling functions that are not well understood. Here, we examined how TIMP-1-dependent cell signaling impacts inflammatory hypersensitivity and ongoing pain. We found that hindpaw injection of complete Freund's adjuvant (CFA) increased cutaneous TIMP-1 expression that peaked prior to development of mechanical hypersensitivity, suggesting that TIMP-1 inhibits the development of inflammatory hypersensitivity. To examine this possibility, we injected TIMP-1 knockout (T1KO) mice with CFA and found that T1KO mice exhibited rapid onset thermal and mechanical hypersensitivity at the site of inflammation that was absent or attenuated in WT controls. We also found that T1KO mice exhibited hypersensitivity in adjacent tissues innervated by different sets of afferents, as well as skin contralateral to the site of inflammation. Replacement of recombinant murine (rm)TIMP-1 alleviated hypersensitivity when administered at the site and time of inflammation. Administration of either the MMP inhibiting N-terminal or the cell signaling C-terminal domains recapitulated the antinociceptive effect of full-length rmTIMP-1, suggesting that rmTIMP-1inhibits hypersensitivity through MMP inhibition and receptor-mediated cell signaling. We also found that hypersensitivity was not due to genotype-specific differences in MMP-9 activity or expression, nor to differences in cytokine expression. Administration of rmTIMP-1 prevented mechanical hypersensitivity and ongoing pain in WT mice, collectively suggesting a novel role for TIMP-1 in the attenuation of inflammatory pain.

UI MeSH Term Description Entries

Related Publications

Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
December 2004, Experimental cell research,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
May 2019, Molecular neurobiology,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
August 2009, Inflammation,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
January 2016, Gastroenterology research and practice,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
October 2008, World journal of surgical oncology,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
August 2012, Oral surgery, oral medicine, oral pathology and oral radiology,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
January 2023, PloS one,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
July 2005, The Journal of biological chemistry,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
January 2011, British journal of pharmacology,
Brittany E Knight, and Nathan Kozlowski, and Joshua Havelin, and Tamara King, and Stephen J Crocker, and Erin E Young, and Kyle M Baumbauer
October 2022, Journal of neuroinflammation,
Copied contents to your clipboard!